Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | CTSD | P07339 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.56 |
| ▸ | XBP1 | P17861 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | STAT3 | P40763 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl 2-Methoxybenzoate SCHEMBL29702077 | 0.87 | TSHR (0.69) | HPGDALDH1A1CTSDNPC1SMN1; SMN2 | |
| Methyl 2-Methoxybenzoate SCHEMBL196037 | 0.87 | TSHR (0.69) | HPGDALDH1A1CTSDNPC1SMN1; SMN2 | |
| SCHEMBL48968 | 0.87 | HPGD (0.59) | HPGDALDH1A1CTSDNPC1SMN1; SMN2 | |
| SCHEMBL446339 | 0.87 | HPGD (0.59) | HPGDALDH1A1CTSDNPC1SMN1; SMN2 | |
| Methyl 2-Methoxybenzoate SCHEMBL30744939 | 0.85 | MAPT (0.67) | HPGDALDH1A1CTSDNPC1SMN1; SMN2 | |
| SCHEMBL125031 | 0.83 | HPGD (0.56) | HPGDALDH1A1CTSDNPC1SMN1; SMN2 | |
| SCHEMBL8852648 | 0.83 | HPGD (0.56) | HPGDALDH1A1CTSDNPC1SMN1; SMN2 | |
| SCHEMBL16056712 | 0.83 | HPGD (0.56) | HPGDALDH1A1CTSDNPC1SMN1; SMN2 | |
| SCHEMBL17641437 | 0.83 | CTSD (0.59) | HPGDALDH1A1CTSDNPC1SMN1; SMN2 | |
| SCHEMBL31321657 | 0.83 | ESR1 (0.66) | HPGDALDH1A1CTSDNPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6951904-B1 | Process for increasing the melt strength of polypropylene | POLYMERS AUSTRALIA PTY LIMITED (AU) | 2005-10-04 | — | — | US | claimed |
| EP-1080148-A4 | PROCESS FOR INCREASING THE MELT STRENGTH OF POLYPROPYLENE | POLYMERS AUSTRALIA PTY LTD (AU) | 2003-02-05 | — | — | EP | claimed |
| EP-1080148-A1 | PROCESS FOR INCREASING THE MELT STRENGTH OF POLYPROPYLENE | Polymers Australia PTY Limited (AU) | 2001-03-07 | — | — | EP | claimed |
| WO-1999036466-A1 | PROCESS FOR INCREASING THE MELT STRENGTH OF POLYPROPYLENE | POLYMERS AUSTRALIA PTY LIMITED (AU) | 1999-07-22 | — | — | WO | claimed |
| EP-0149236-B1 | PROCESS FOR THE PRODUCTION OF MOULDED BODIES WHICH ARE CELLULAR OR NOT | BAYER AG (DE) | 1988-07-20 | — | — | EP | claimed |
| EP-0149236-A2 | Process for the production of moulded bodies which are cellular or not | BAYER AG (DE) | 1985-07-24 | — | — | EP | claimed |
| EP-3413726-B1 | VITAMIN COMPOSITION | NESTLE SA (CH) | 2024-03-13 | — | — | EP | disclosed |
| EP-3983369-A1 | PROCESS FOR THE PRODUCTION OF DIACYL PEROXIDES | Nouryon Chemicals International B.V. (NL) | 2022-04-20 | — | — | EP | disclosed |
| US-11203729-B2 | Unsaturated macrocyclic epoxide as perfuming ingredient | FIRMENICH SA (CH) | 2021-12-21 | — | — | US | disclosed |
| WO-2021211923-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASE | PULMOQUINE THERAPEUTICS, INC. (US) | 2021-10-21 | — | — | WO | disclosed |
| WO-2020249690-A1 | PROCESS FOR THE PRODUCTION OF DIACYL PEROXIDES | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2020-12-17 | — | — | WO | disclosed |
| CN-106232786-B | Unsaturated macrocyclic epoxides as perfuming ingredients | 弗门尼舍有限公司 | 2020-08-07 | — | — | CN | disclosed |
| EP-3618613-A1 | COMPOSITION CONTAINING CHLORINE DIOXIDE AND METHODS FOR USING SAME | Pamel, Gregory J. (US) | 2020-03-11 | — | — | EP | disclosed |
| EP-0149236-A2 | Process for the production of moulded bodies which are cellular or not | BAYER AG (DE) | 1985-07-24 | — | — | EP | disclosed |
| US-4486327-A | FOR PEROXYGEN COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1984-12-04 | — | — | US | disclosed |
| US-4483778-A | Peroxygen bleach activators and bleaching compositions | THE PROCTER & GAMBLE COMPANY (US) | 1984-11-20 | — | — | US | disclosed |
| EP-0102007-A2 | Process for producing moulded articles which can be cellular | BAYER AG (DE) | 1984-03-07 | — | — | EP | disclosed |
| EP-0024680-B1 | POWDER PAINT BINDERS AND PROCESS FOR THEIR PREPARATION | BAYER AG (DE) | 1982-06-09 | — | — | EP | disclosed |
| EP-0024680-A1 | Powder paint binders and process for their preparation | BAYER AG (DE) | 1981-03-11 | — | — | EP | disclosed |
| US-3935138-A | ADDITION COPOLYMER AND TRIGLYCIDYL ISOCYANURATE, BISOXAZOLINE OR TRIS-OXAZOLINE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11203729-B2 | Unsaturated macrocyclic epoxide as perfuming ingredient | PTGES, TECR, EPHX2 | HPGD 21/4885ALDH1A1 607/4885CTSD 2031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.